Endoscopy 2002; 34(5): 421-423
DOI: 10.1055/s-2002-25288
Case Report

© Georg Thieme Verlag Stuttgart · New York

Development of an Aggressive Depressed Cancer in a Case of Familial Adenomatous Polyposis

Y.  Saito 1 , T.  Fujii 1 , T.  Akasu 2 , T.  Gotoda 1 , T.  Kozu 1 , D.  Saito 1 , Y.  Sano 3
  • 1Division of Gastrointestinal Endoscopy, National Cancer Center Hospital, Tokyo, Japan
  • 2Surgical Oncology, National Cancer Center Hospital, Tokyo, Japan
  • 3Division of Endoscopy and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan
Further Information

Publication History

6 July 2001

13 November 2001

Publication Date:
22 April 2002 (online)

In 1977, Kariya et al. reported a case of a small depressed cancer in a patient with familial adenomatous polyposis (FAP) raising the possibility that not all cancers in FAP develop from polypoid adenomas. It is now becoming widely recognized that colonic adenomas may appear as flat or depressed lesions. However, colorectal cancers developing in patients with familial adenomatous polyposis (FAP) are still thought to evolve from adenomatous polyps following the polyp-carcinoma sequence. We report the case of a patient with FAP in whom rectal carcinoma developed 23 years after subtotal colectomy and ileorectal anastomosis. We suggest that this malignancy may have developed de novo because of the depressed shape of the lesion and the aggressive growth pattern. This case raises the possibility that carcinomas may not always evolve from polyps in FAP. Aggressive cancers with a depressed appearance should be searched for when surveying the rectal stump in patients with FAP.

References

  • 1 Kariya A, Beppu Y, Mizuno M. et al . A case of early colonic cancer type IIc associated with familial polyposis coli (in Japanese with English summary).  Stomach Intest. 1977;  12 1359-1364
  • 2 Fujii T, Rembacken B J, Dixon M F. et al . Flat adenomas in the United Kingdom - are treatable cancers being missed?.  Endoscopy. 1998;  30 437-443
  • 3 Rembacken B J, Fujii T, Cairns A. et al . Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK.  Lancet. 2000;  355 1211-1214
  • 4 Vogelstein B, Fearon E R, Hamilton S R. et al . Genetic alterations during colorectal tumor development.  N Engl J Med. 1998;  319 525-532
  • 5 Morson B C. Precancerous and early malignant lesions of the large intestine.  Br J Surg. 1968;  55 725-735
  • 6 Kudo S, Kashida H, Nakajima T. et al . Endoscopic diagnosis and treatment of early colorectal cancer.  World J Surg. 1997;  21 694-701
  • 7 Kudo S, Hirota S, Nakajima T. et al . Colorectal tumors and pit pattern.  J Clin Pathol. 1994;  47 880-885
  • 8 Nakada I, Tasaki T, Ubukata H. et al . Desmoplastic response of early colorectal carcinoma is predictive of deep submucosal invasion.  Dis Colon Rectum. 1998;  41 896-900
  • 9 Kusaka T, Fukui H, Sano Y. et al . Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.  J Gastroenterol Hepatol. 2000;  15 (10) 1151-1157
  • 10 Arao J, Sano Y, Fujii T. et al . Cyclooxygenase-2 is overexpressed in serrated adenoma of the colorectum.  Dis Colon Rectum. 2001;  44 1319-1323
  • 11 Trecca A, Fujii T, Kato S. Small advanced colorectal carcinomas: report on three cases.  Endoscopy. 1998;  30 493-495
  • 12 Yamagata S, Muto T, Uchida Y. et al . Lower incidence of K-ras codon mutation in flat colorectal adenomas than in polypoidal adenomas.  Jpn J Cancer Res. 1994;  85 147-151
  • 13 Minamoto T, Sawaguchi K, Mai M. et al . Infrequent K-ras activation in superficial type (flat) colorectal adenomas and adenocarcinomas.  Cancer Res. 1994;  54 2841-2844
  • 14 Waddell W R, Loughry R W. Sulindac for polyposis of the colon.  J Surg Oncol. 1983;  24 83-87
  • 15 Waddel W R, Ganser G F, Cerise E J. et al . Sulindac for polyposis of the colon.  Am J Surg. 1989;  157 175-178
  • 16 Rigau J, Pique J M, Rubio E. et al . Effects of long-term sulindac therapy on colonic polyposis.  Ann Intern Med. 1991;  115 952-954
  • 17 Labayle D, Fischer D, Vielh P. et al . Sulindac causes regression of rectal polyps in familial adenomatous polyposis.  Gastroenterology. 1991;  101 635-639
  • 18 Parker A L, Kadakia S C, Maccini D M. et al . Disappearance of duodenal polyps in Gardner's syndrome with sulindac therapy.  Am J Gastroenterol. 1993;  88 93-94
  • 19 Giardello F M, Hamilton S R, Krush A J. et al . Treatment of colonic and rectal adenomas with sulindac in familial adenomatous coli.  N Engl J Med. 1993;  328 1313-1316
  • 20 Gonzaga R AF, Lima F R, Carneiro S. et al . Sulindac treatment for familial polyposis (letter).  Lancet. 1985;  1 751
  • 21 Friend W G. Sulindac suppression of colorectal polyps in Gardner's syndrome.  Am Fam Physician. 1990;  41 891-894
  • 22 Nugent K P, Farmer K CR, Spigelman A D. et al . Randomized controlled clinical trial of sulindac on intestinal polyposis in FAP (abstract).  Gut. 1992;  33 S33
  • 23 Lynch H T, Thorson A G, Smyrk T. Rectal cancer after prolonged sulindac chemoprevention.  Cancer. 1995;  75 936-938
  • 24 Niv Y, Fraser G M. Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy.  Gastroenterology. 1994;  107 854-857

Y. Saito, M.D.

Division of Gastrointestinal Endoscopy · National Cancer Center Hospital

5-1-1 Tsukiji · Chuo-ku · Tokyo 104 · Japan

Phone: + 81-3-3542-2511 ·

Fax: + 81-3-3542-3815

Email: ytsaito@mitsuihosp.or.jp

    >